These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11080748)

  • 1. Coronary stent implantation in diabetic versus nondiabetic patients. Early and late outcomes.
    Bayerl DM; Siqueira E; Moscoso I; Santos E; Maeda A; Bittencourt O; Mauro MF; Cristovão S; Salman A; Sanches G; Mangione JA
    Arq Bras Cardiol; 2000 Nov; 75(5):365-8. PubMed ID: 11080748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation.
    Abizaid A; Kornowski R; Mintz GS; Hong MK; Abizaid AS; Mehran R; Pichard AD; Kent KM; Satler LF; Wu H; Popma JJ; Leon MB
    J Am Coll Cardiol; 1998 Sep; 32(3):584-9. PubMed ID: 9741497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stenting in diabetics: six months clinical and angiographic outcome.
    Kane GR; Patil CV; Sahoo PK; Bhatnagar D; Mathew R; Sethi RB
    Indian Heart J; 2000; 52(4):416-20. PubMed ID: 11084782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
    Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial.
    Mattos LA; Grines CL; Sousa JE; Sousa AG; Stone GW; Cox D; Garcia E; Morice MC; O'Neill W; Grines L; Boura J
    Arq Bras Cardiol; 2001 Dec; 77(6):549-61. PubMed ID: 11799430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome.
    Silva JA; Ramee SR; White CJ; Collins TJ; Jenkins JS; Nunez E; Zhang S; Jain SP
    Am Heart J; 1999 Sep; 138(3 Pt 1):446-55. PubMed ID: 10467194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results after drug-eluting stent implantation in diabetic patients according to diabetic treatment.
    Voudris V; Karyofillis P; Thomopoulou S; Doulaptsis C; Manginas A; Pavlides G; Cokkinos DV
    Hellenic J Cardiol; 2011; 52(1):15-22. PubMed ID: 21292603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).
    Yee KM; Buller CE; Catellier D; Cohen EA; Carere RC; Anderson T; Berger P; Burton JR; Barbeau G; Teo KK; Dzavik V;
    Catheter Cardiovasc Interv; 2005 Oct; 66(2):178-84. PubMed ID: 15977265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
    Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
    Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
    Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era.
    Ashfaq S; Ghazzal Z; Douglas JS; Morris DC; Veledar E; Weintraub WS
    J Invasive Cardiol; 2006 Mar; 18(3):100-5. PubMed ID: 16598106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.